Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma.
about
Time-dependent endpoints as predictors of overall survival in multiple myelomaLenalidomide for multiple myeloma: cost-effectiveness in patients with one prior therapy in England and Wales.On an enhanced rank-preserving structural failure time model to handle treatment switch, crossover, and dropout.Methods for adjusting for bias due to crossover in oncology trials.Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone
P2860
Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Adjusting for patient crossove ...... for advanced multiple myeloma.
@ast
Adjusting for patient crossove ...... for advanced multiple myeloma.
@en
type
label
Adjusting for patient crossove ...... for advanced multiple myeloma.
@ast
Adjusting for patient crossove ...... for advanced multiple myeloma.
@en
prefLabel
Adjusting for patient crossove ...... for advanced multiple myeloma.
@ast
Adjusting for patient crossove ...... for advanced multiple myeloma.
@en
P2093
P50
P1433
P1476
Adjusting for patient crossove ...... for advanced multiple myeloma
@en
P2093
Arran Shearer
Bradley Augustson
Donna Weber
Gulnaz Iqbal
J Anthony Child
Janet Dunn
K Jack Ishak
Mark T Drayson
Robert Knight
P304
P356
10.1016/J.JVAL.2011.02.1182
P577
2011-07-01T00:00:00Z